Abstract:Objective MiRNAs microarray was employed to determine the differential time-specific expression of miRNAs in ventricular myocardium of fetus with ventricular septal defect(VSD) in the different gestational ages(the first trimester and the second trimester).Methods The VSD group was recruited from the fetuses with VSD aborted for pathological factors,and was divided into VSD subgroups:subgroup 1 for the first trimester and subgroup 2 for the second trimester according to the gestational ages.The control group was chosen from the fetuses of inevitable abortion without cardiac malformations,and was divided into the control subgroups in the same way.The fetal ventricular myocardiums were acquired and RNAs were extracted and processed.The Agilent Human 2.0 microarrays containing 723 known miRNAs were applied to get the data about miRNAs expression changes,the data were analyzed by bioinformatics methods:differential miRNAs expression analysis,target gene ontology analysis and pathway-express analysis.Differential expressions of miRNAs microarray were certificated by real-time PCR.Results VSD group and control group had 6 fetuses,respectively,with 3 fetuses in the first trimester and 3 in the second trimester,respectively.①There were 33 differential time-specific expression of miRNAs in the 2 VSD subgroups.Expressions of 19 miRNAs were up-regulated in subgroup 1 and down-regulated in subgroup 2.Expressions of 14 miRNAs were up-regulated in subgroup 1 and down-regulated in subgroup 2.②A total of 2 761 target genes were predicted by bioinformatic methods.The most of target genes were directly associated with the key genes of heart development(such as TBX5,GATA4,TBX1,NKX2-5,etc.).③The gene ontology analysis indicated that target genes were mainly related to the cellular process,metabolic process and biological regulation,and accounted for 23.5 %,18.3%,17.7% of the total number of target genes,respectively.④The pathway-express analysis indicated that the WNT signaling pathway played an important role in both VSD subgroups.⑤Four miRNAs(hsa-miR-19a,hsa-let-7e,hsa-miR-134 and hsa-miR-206) were randomly selected and verified by real-time PCR,the results of quantitative PCR were basically consistent with the microarray results.Conclusions The differential time-specific expression of miRNAs may play an important role in the occurrence and development of fetal VSD malformations,but it needs confirmation by study with larger sample size.These predicted target genes were mainly related to cell growth,differentiation and metabolism;partially were directly associated with the key genes of heart development;partially were key factors of the WNT signaling pathway.The occurrence and development of fetal VSD malformations were the joint results of imbalance gene expression which functioned at different levels under the participation of miRNAs.

Screening and Identification of Genes in Myocardial Tissue of Fetus with Ventricular Septal Defect by Using Human Genome Microarray

Differential Time-Specific Expression of Mirnas in Ventricular Myocardium of Fetus with Ventricular Septal Defect

Screening of Tetralogy of Fallot-Associated Genes Using Gene Microarrays

Microrna Expression Profiling in Fetal Single Ventricle Malformation Identified by Deep Sequencing.

The Role of Microrna -155,Microrna -222 and Mitogen -Activated Protein Kinase Signaling Pathway in Ven-Tricular Septal Defect

Characterization of Circulating MicroRNA Expression in Patients with a Ventricular Septal Defect

microRNA EXPRESSION PROFILING OF CARDIAC TISSUE DURING FETAL DEVELOPMENT 1251 vital role by regulating heart gene expression in heart

Microrna Expression Profiling of Heart Tissue During Fetal Development

Differential Expression of CircRNAs in Embryonic Heart Tissue Associated with Ventricular Septal Defect

Screening of Molecular Biomarkers Associated with Heart Failure Derived from Arrhythmogenic Right Ventricular Cardiomyopathy

Novel NKX2-5 Mutations Identified in Patients with Congenital Ventricular Septal Defects

Genome-wide Methylation Analysis Reveals Differentially Methylated CpG Sites and Altered Expression of Heart Development-Associated Genes in Fetuses with Cardiac Defects

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

A Novel NKX2-5 Mutation in Familial Ventricular Septal Defect.

Clinical Application of Chromosomal Microarray Analysis in Fetuses with Congenital Heart Disease

Differential lncRNA/mRNA expression profiling and ceRNA network analyses in amniotic fluid from foetuses with ventricular septal defects

Placental epigenetics for evaluation of fetal congenital heart defects: Ventricular septal defect (VSD)

Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects

Prenatal genetic diagnosis associated with fetal ventricular septal defect: an assessment based on chromosomal microarray analysis and exome sequencing

Elevated Cell-Free RNA in Maternal Circulation During Single Ventricle Heart Defect Pregnancies Dysregulate Human Cardiomyocyte Proliferation

Expression Profile of Maternal Circulating Micrornas As Non-Invasive Biomarkers for Prenatal Diagnosis of Congenital Heart Defects.